Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited
understanding of brain metastasis tumor and immune biology, drivers of resistance to …

Kidney cancer is the 13th most common malignancy globally, and the incidence is rising.
Papillary renal cell carcinoma is the second most common subtype, comprising 10-15% of …

Importance There exists considerable biological and clinical variability between histologic
variants of metastatic renal cell carcinoma (mRCC). Data reporting on patterns of metastasis …

Doublecortin-like kinase 1 (DCLK1), a protein molecule, has been identified as a tumor stem
cell marker in the cancer cells of gastrointestine, pancreas, and human colon. DCLK1 …

Existing data on the prognosis and clinicopathological features of patients with metastatic
renal cell carcinoma (mRCC) are limited. This study aims to investigate the prognostic value …

Purpose: Lymph node dissection may benefit patients at increased risk for lymph node
metastases from renal cell carcinoma. Therefore, we evaluated the association of lymph …

As with any other intervention in health, liver transplantation (LT) entails a variety of risks,
including donor-transmitted cancers (DTCs). At present, 2%–4% of used deceased organ …

Bufalin, one of the active ingredients of the Chinese drug Chan su, exhibits significant
antitumor activity against various cancer types. However, the role of bufalin in renal cell …

Background. Bone metastasis (BM) is one of the common sites of renal cell carcinoma
(RCC), and patients with BM have a poorer prognosis. We aimed to develop two …

Background: Elderly people are at high risk of metastatic kidney cancer (KC), and, the bone
is one of the most common metastatic sites for metastatic KC. However, studies on …